The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
Dr. Erika Hamilton not too long ago mentioned her work on the HER2CLIMB05 medical trial evaluating Tukysa (tucatinib) together with Herceptin (trastuzumab)...
Final yr introduced notable developments in blood most cancers remedy and analysis, highlighting a number of myeloma, lymphoma, leukemia and myelodysplastic syndromes....
